Jump to content
IndiaDivine.org

Merck Says Vioxx Risks [May] Apply to Whole Drug Class (Update3)

Rate this topic

Guest guest

By Guest guest
in Ayurveda, Health and Wellbeing

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

SSRI-Research@

Fri, 18 Feb 2005 12:49:25 -0000

 

 

[sSRI-Research] Merck Says Vioxx Risks [May] Apply to Whole

Drug Class (Update3)

 

Bloomberg.com, Wed, 16 Feb 2005 12:09 PM PST

 

Merck Says Vioxx Risks May Apply to Whole Drug Class (Update3)

 

http://www.bloomberg.com/apps/news?pid=10000087 & sid=aiuBJP39yE7Q

 

Feb. 16 (Bloomberg) -- Merck & Co. told U.S. Food and Drug

Administration advisers today that research linking its withdrawn

Vioxx to heart attacks and strokes may apply to the entire class of

painkillers known as Cox-2 inhibitors.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing

Support the Ashram

Join Groups

IndiaDivine Telegram Group IndiaDivine WhatsApp Group


×
×
  • Create New...